Abhay Phansalkar M.D. Epgbm

About Abhay Phansalkar M.D. Epgbm

Transformative Leadership, Advancing Global Medical Strategy, Clinical Innovation, and Patient OutcomesI am a global medical affairs, clinical development and pharmacovigilance leader with 20+ years of experience shaping enterprise-wide medical strategy, advancing patient‑centered innovation, and delivering measurable clinical and organizational impact within strict regulatory and compliance frameworks. I specialize in crafting evidence‑based medical strategies and driving launch excellence across therapies, including oncology, respiratory, and vaccines — integrating clinical trials, real‑world evidence (RWE), non‑interventional studies (NIS), drug safety and health economics (HEOR) to shape healthcare landscapes and stakeholder beliefs, accelerate access, inform policy, and improve patient outcomes worldwide.Digital and AI Innovation Catalyst: I pilot and embed digital and AI solutions across the medical value chain to drive measurable outcomes — accelerating evidence generation, reducing time‑to‑insight, enhancing regulatory readiness, and improving patient access and outcomes at scale.Building High-Performance, Science-Led & Patient-Centered TeamsI take pride in building medical teams that operate with integrity, agility, and purpose. From strengthening MSL capability to excellence in external stakeholder engagements, I focus on embedding data-driven scientific excellence and strategic alignment throughout the organization for the medical teams.Trusted Advisor to Global and Regional Leadership & Cross-functional CollaboratorAs a trusted advisor to executive leadership, and partner to R&D, regulatory, access, and commercial teams, I have led initiatives that enhance medical launch readiness, scale evidence strategies, and accelerate therapy adoption across complex, multicultural environments—delivering measurable public health and business impact.

Experience

1. Regional Medical Scientific Director (Em Hematology Oncology)

   GSK

   Nov 2024 — Present · Mumbai, IN

   I serve as a transformative regional medical affairs leader, focusing on Oncology and Hematology strategies across multiple regions including India, LATAM, Middle East & North Africa, and Asia Pacific, shaping pre- and launch excellence and cross-functional integration. I lead AI-enabled initiatives—HCP insight generation, predictive modelling, patient journey mapping, and omnichannel medical education—aligning regional goals with global vision. I advance evidence generation through RWE, HEOR (20+ study proposals evaluated), strategic publications (2 authored, 5 reviewed as publication accountable person), scientific engagement excellence through medical capability development program (50+ Medics & MSLs, therapy and communication excellence, omnichannel and digital fluency and launch leadership), Medical Education preceptorship workshops, congresses presence, and patient advocacy, mentoring teams to translate AI enabled actionable insights into impactful HCP belief and advocacy shifts and healthcare outcomes globally.

Education

• Indian Institute of Management, Calcutta

  Executive MBA in Global Business Management , Business Administration and Management, General

  2017 — 2018

• The Accreditation Council for Medical Affairs

  BCMAS (Board Certified Medical Affairs Specialist), Medical Affairs

  2020 — 2021

• NTR University of Health Sciences

  MD, Pharmacology

  2004 — 2007

Skills

• Clinical Study Design
• Clinical Trials
• Good Clinical Practice (Gcp)
• Therapeutic Areas
• Clinical Research
• Clinical Pharmacology
• Ich-Gcp
• Gcp
• Clinical Development
• Oncology
• Protocol
• Pharmacovigilance
• Regulatory Submissions
• Health Economics
• Epidemiology
• Regulatory Affairs
• Infectious Diseases
• Medical Writing
• Medical Affairs
• Pharmaceutical Industry
• Drug Safety